Results 161 to 170 of about 1,587,717 (295)

Expanding disease resistance: engineered NLRS for broad-spectrum protection. [PDF]

Mol Hortic
Zhou T, Wang J, Wang Y.
europepmc   +1 more source

Iron deficiency anemia of unknown etiology and/or resistance to the treatment: The sole manifestation of adult celiac disease (CD) [PDF]

, 1999
Mustafa Nuri Yenerel, Sevgi Kalayo lu‐Beşişik   +1 more
openalex   +1 more source

Disease resistant plants

, 2007
The present invention relates to methods for producing plants having enhanced disease resistance. NRCl proteins and nucleic acid sequences encoding these are provided, as well as transgenic plants producing NRCl proteins.
Gabriëls, S.H.E.J., Vossen, J.H., Joosten, M.H.A.J., de Wit, P.J.G.M.   +3 more
openaire   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Targeted expansion of a barley genebank core collection facilitates the discovery of disease resistance loci. [PDF]

Theor Appl Genet
Yuan Z, Zhao Y, Oldach K, Jahoor A, Jensen JD, Dohrendorf VE, Eschholz TW, Roescher S, Stein N, Reif JC, El Hanafi S.   +10 more
europepmc   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

Effects of soybean intercropping density on photosynthetic characteristics and disease resistance in tobacco. [PDF]

Front Plant Sci
Liu X, Hu Y, Yang C, Li J, Lu C, Tian N, Zhou H, Jin S, Su J, Wang D, Xu C, Huang Y, Liu M.   +12 more
europepmc   +1 more source

Active defense as a mechanism of resistance in pine against pine wilt disease.

, 1989
Hachiro Oku, Tomonori Shiraishi, Kei CHIKAMATSU   +2 more
openalex   +2 more sources

Resistance to Malignant Disease [PDF]

BMJ, 1946
openaire   +2 more sources

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source